Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTSC has considrable leverage over TPL

<I believe they had/have an affirmative duty to clarify once "Gloria's email" became public, >

I take note that the above statement is your belief only, not an SEC requirement or some other legally binding requirement. May I further presume that if indeed there was some legally binding requirement that you have informed PTSC of the fact? If not, why?

Opty

Share
New Message
Please login to post a reply